[1]
“The exacerbation of multiple sclerosis by COVID-19 and its aspects in relation to disease modulating therapies: a narrative review”, Acervo Saúde, vol. 13, no. 11, p. e9088, Nov. 2021, doi: 10.25248/reas.e9088.2021.